186 related articles for article (PubMed ID: 2648253)
1. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.
Lemoine NR; Mayall ES; Wyllie FS; Williams ED; Goyns M; Stringer B; Wynford-Thomas D
Oncogene; 1989 Feb; 4(2):159-64. PubMed ID: 2648253
[TBL] [Abstract][Full Text] [Related]
2. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
Bouras M; Parvaz P; Berger N; Paulin C; Revol A
Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
[TBL] [Abstract][Full Text] [Related]
3. Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors.
Challeton C; Bounacer A; Du Villard JA; Caillou B; De Vathaire F; Monier R; Schlumberger M; Suárez HG
Oncogene; 1995 Aug; 11(3):601-3. PubMed ID: 7630645
[TBL] [Abstract][Full Text] [Related]
4. Presence of mutations in all three ras genes in human thyroid tumors.
Suarez HG; du Villard JA; Severino M; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1990 Apr; 5(4):565-70. PubMed ID: 2183158
[TBL] [Abstract][Full Text] [Related]
5. High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area.
Shi YF; Zou MJ; Schmidt H; Juhasz F; Stensky V; Robb D; Farid NR
Cancer Res; 1991 May; 51(10):2690-3. PubMed ID: 2021946
[TBL] [Abstract][Full Text] [Related]
6. [Demonstration of activated oncogenes of the ras family in human thyroid tumors using the polymerase chain reaction].
Dockhorn-Dworniczak B; Caspari S; Schröder S; Böcker W; Dworniczak B
Verh Dtsch Ges Pathol; 1990; 74():415-8. PubMed ID: 1708628
[TBL] [Abstract][Full Text] [Related]
7. Radiation-associated and 'spontaneous' human thyroid carcinomas show a different pattern of ras oncogene mutation.
Wright PA; Williams ED; Lemoine NR; Wynford-Thomas D
Oncogene; 1991 Mar; 6(3):471-3. PubMed ID: 2011403
[TBL] [Abstract][Full Text] [Related]
8. N-ras 61 oncogene mutations in Hürthle cell tumors.
Schark C; Fulton N; Jacoby RF; Westbrook CA; Straus FH; Kaplan EL
Surgery; 1990 Dec; 108(6):994-9; discussion 999-1000. PubMed ID: 2247846
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA
Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289
[TBL] [Abstract][Full Text] [Related]
10. Detection of activated ras oncogenes in human thyroid carcinomas.
Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
[TBL] [Abstract][Full Text] [Related]
11. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
[TBL] [Abstract][Full Text] [Related]
12. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
[TBL] [Abstract][Full Text] [Related]
13. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G
J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056
[TBL] [Abstract][Full Text] [Related]
14. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient.
Zauber NP; Sabbath-Solitare M; Marotta SP; Zauber AG; Bishop DT
J Pathol; 2001 Mar; 193(3):303-9. PubMed ID: 11241408
[TBL] [Abstract][Full Text] [Related]
15. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
16. Variability of Ha-ras (codon 12) proto-oncogene mutations in diverse thyroid cancers.
Bouras M; Bertholon J; Dutrieux-Berger N; Parvaz P; Paulin C; Revol A
Eur J Endocrinol; 1998 Aug; 139(2):209-16. PubMed ID: 9724079
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
18. Ras oncogene mutations in benign and malignant thyroid neoplasms.
Karga H; Lee JK; Vickery AL; Thor A; Gaz RD; Jameson JL
J Clin Endocrinol Metab; 1991 Oct; 73(4):832-6. PubMed ID: 1890154
[TBL] [Abstract][Full Text] [Related]
19. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
Namba H; Rubin SA; Fagin JA
Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
[TBL] [Abstract][Full Text] [Related]
20. Absence of activating mutations in ras and gsp oncogenes in a cohort of nine patients with sporadic pediatric thyroid tumors.
Pauws E; Tummers RF; Ris-Stalpers C; de Vijlder JJ; Voûte T
Med Pediatr Oncol; 2001 Jun; 36(6):630-4. PubMed ID: 11344494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
